tiprankstipranks
pc:artio

Artios Pharma Limited

A biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage response (DDR) in cancer. Artios is pioneering next-generation approaches in the DDR field through its comprehensive anti-cancer approach and the deep experience of its team of DDR drug developers.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$115M
Total Amount Raised$115M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$115M
Latest Funding Amount$115M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation
Post-Money Valuation

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 17, 2025
Series D
$115.00M

Investors

Investor Name
Funding Round

Related News and Analysis